Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.45 |
| ▸ | ESR2 | Q92731 | 3/20 | 0.45 |
| ▸ | CHRM3 | P20309 | 4/20 | 0.43 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.42 |
| ▸ | KIF11 | P52732 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | ESR1 | P03372 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | CHRM2 | P08172 | 3/20 | 0.40 |
| ▸ | CHRM4 | P08173 | 3/20 | 0.40 |
| ▸ | CHRM5 | P08912 | 3/20 | 0.40 |
| ▸ | CHRM1 | P11229 | 3/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23013768 | 0.94 | SIGMAR1 (0.45) | CYP1A2CYP2C9CYP2C19ESR2CHRM3 | |
| SCHEMBL27294657 | 0.92 | MEN1 (0.44) | CYP1A2CYP2C9CYP2C19ESR2CHRM3 | |
| SCHEMBL62287 | 0.92 | CYP1A2 (0.48) | CYP1A2CYP2C9CYP2C19ESR2CHRM3 | |
| SCHEMBL31590437 | 0.90 | CYP1A2 (0.47) | CYP1A2CYP2C9CYP2C19ESR2CHRM3 | |
| SCHEMBL27973516 | 0.88 | CYP1A2 (0.45) | CYP1A2CYP2C9CYP2C19ESR2CHRM3 | |
| Alcohol SCHEMBL28670006 | 0.88 | CYP1A2 (0.45) | CYP1A2CYP2C9CYP2C19ESR2CHRM3 | |
| SCHEMBL23014014 | 0.88 | CYP2C19 (0.48) | CYP1A2CYP2C9CYP2C19ESR2CHRM3 | |
| SCHEMBL29703352 | 0.86 | ESR2 (0.44) | CYP1A2CYP2C9CYP2C19ESR2CHRM3 | |
| SCHEMBL29161136 | 0.86 | SIGMAR1 (0.45) | CYP1A2CYP2C9CYP2C19ESR2SIGMAR1 | |
| SCHEMBL28724610 | 0.86 | SIGMAR1 (0.45) | CYP1A2CYP2C9CYP2C19ESR2SIGMAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12221458-B2 | Organic borate-based catalyst, method for preparing isobutene oligomer using the same and isobutene oligomer prepared thereby | LG CHEM, LTD. (KR) | 2025-02-11 | — | — | US | disclosed |
| CN-118542857-A | Application of 1-phenyl-1-propanol in preparation of medicines for treating depression and/or anxiety | 张利生 | 2024-08-27 | — | — | CN | disclosed |
| EP-4019128-B1 | ORGANIC BORATE-BASED CATALYST, METHOD FOR PREPARING ISOBUTENE OLIGOMER BY USING SAME, AND ISOBUTENE OLIGOMER PREPARED THEREBY | LG CHEMICAL LTD (KR) | 2024-02-21 | — | — | EP | disclosed |
| CN-113661185-B | Organoborate catalyst, process for producing isobutylene oligomer using the same, and isobutylene oligomer produced thereby | 株式会社LG化学 | 2023-12-29 | — | — | CN | disclosed |
| US-20230271988-A1 | METHOD FOR PRODUCING ORGANOMETALLIC NUCLEOPHILE AND REACTION METHOD USING ORGANOMETALLIC NUCLEOPHILE | NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY (JP) | 2023-08-31 | — | — | US | disclosed |
| US-20220204533-A1 | Organic Borate-Based Catalyst, Method For Preparing Isobutene Oligomer Using The Same And Isobutene Oligomer Prepared Thereby | LG CHEM, LTD. (KR) | 2022-06-30 | — | — | US | disclosed |
| EP-4019128-A1 | ORGANIC BORATE-BASED CATALYST, METHOD FOR PREPARING ISOBUTENE OLIGOMER BY USING SAME, AND ISOBUTENE OLIGOMER PREPARED THEREBY | LG CHEM, LTD. (KR) | 2022-06-29 | — | — | EP | disclosed |
| CN-113661185-A | Organic borate catalyst, method for preparing isobutylene oligomer using the same, and isobutylene oligomer prepared thereby | 株式会社LG化学 | 2021-11-16 | — | — | CN | disclosed |
| WO-2021034041-A1 | ORGANIC BORATE-BASED CATALYST, METHOD FOR PREPARING ISOBUTENE OLIGOMER BY USING SAME, AND ISOBUTENE OLIGOMER PREPARED THEREBY | 주식회사 엘지화학 | 2021-02-25 | — | — | WO | disclosed |
| US-6660884-B2 | Catalyst promote synthesis of tertiary alcohols with enantioselectivity; Bicyclo(2.2.1)heptane-1-methane sulfonamide-N,N'-(1S,2S)-1,2-cyclohexanediylbis(2-hydroxy-7,7-dimethyl) -(1R,1'R,2S,2'S,4S,4'S) | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA | 2003-12-09 | — | — | US | disclosed |
| US-20030191345-A1 | CATALYSTS, METHODS FOR MAKING SAID CATALYSTS, AND METHODS FOR MAKING CHIRAL COMPOUNDS WITH HIGH ENANTIOSELECTIVITY | TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA, THE | 2003-10-09 | — | — | US | disclosed |
| EP-0531715-B1 | Process for producing alcohols and ketones | SUMITOMO CHEMICAL CO (JP) | 1997-11-05 | — | — | EP | disclosed |
| US-5426237-A | Oxidation of straight, branched or cyclic alkanes and benzene derivatives in presence of transition metal catalyst and aldehyde | SUMITOMO CHEMICAL CO., LTD. (JP) | 1995-06-20 | — | — | US | disclosed |
| EP-0531715-A1 | Process for producing alcohols and ketones | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1993-03-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230271988-A1 | METHOD FOR PRODUCING ORGANOMETALLIC NUCLEOPHILE AND REACTION METHOD USING ORGANOMETALLIC NUCLEOPHILE | HPD, TALDO1, OGG1 | CYP1A2 537/4885CYP2C9 241/4885CYP2C19 970/4885 |
| US-20030191345-A1 | CATALYSTS, METHODS FOR MAKING SAID CATALYSTS, AND METHODS FOR MAKING CHIRAL COMPOUNDS WITH HIGH ENANTIOSELECTIVITY | COASY, HMGCR, ALKBH1 | CYP1A2 117/4885CYP2C9 58/4885CYP2C19 183/4885 |
| US-20220204533-A1 | Organic Borate-Based Catalyst, Method For Preparing Isobutene Oligomer Using The Same And Isobutene Oligomer Prepared Thereby | OXER1, ORC3, OSBP | CYP1A2 982/4885CYP2C9 1017/4885CYP2C19 1829/4885 |
| US-12221458-B2 | Organic borate-based catalyst, method for preparing isobutene oligomer using the same and isobutene oligomer prepared thereby | OXER1, ORC3, OSBP | CYP1A2 982/4885CYP2C9 1017/4885CYP2C19 1829/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.